Development and analysis of recombinant BCG vector systems.
Fuerst
T R
TR
Department of Molecular Genetics, MedImmune, Inc., Gaithersburg, MD 20878.
de la Cruz
V F
VF
Bansal
G P
GP
Stover
C K
CK
D016915:AIDS Vaccines / Q000276:immunology; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D000956:Antigens, Viral / Q000096:biosynthesis*; D005822:Genetic Vectors; D015483:HIV Antibodies / Q000096:biosynthesis; D015488:HIV Antigens / Q000096:biosynthesis*; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D015700:HIV Envelope Protein gp41 / Q000276:immunology; D015497:HIV-1 / Q000276:immunology*; D007111:Immunity, Cellular; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D009163:Mycobacterium bovis / Q000235:genetics* / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000276:immunology*; D015302:Simian Immunodeficiency Virus / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
D016915:AIDS Vaccines; D000914:Antibodies, Viral; D000956:Antigens, Viral; D015483:HIV Antibodies; D015488:HIV Antigens; D015699:HIV Envelope Protein gp120; D015700:HIV Envelope Protein gp41; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic; D014765:Viral Vaccines